Form 4: Nanophase Technologies Director Janet Whitmore Increases Stake in Company
SEC Form 4 Filing
Director Janet Whitmore reports multiple open market purchases of Nanophase Technologies (NANX) common stock, increasing her holdings.
Summary
- On August 21 and 22, 2024, Janet Whitmore, a director of Nanophase Technologies Corp (NANX), purchased shares of common stock.
- The purchases were made at prices ranging from $1.57 to $1.60 per share.
- On August 21, she acquired 4,900 shares at $1.57, 118 shares at $1.59, and 100 shares at $1.57.
- On August 22, she acquired 9,822 shares at $1.60, 100 shares at $1.60, 5,900 shares at $1.59, and 100 shares at $1.60.
- Following these transactions, Whitmore directly owns 1,936,781 shares of Nanophase Technologies Corp.
- Whitmore also holds deferred common stock and options to purchase additional shares at various exercise prices and expiration dates.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the director's stock purchases, indicating confidence in the company. However, it's a single transaction and needs to be considered with other factors.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
- Janet Whitmore increased her direct ownership to 1,936,781 shares.
Industry Context
Insider buying is often monitored by investors as a signal of management's confidence in the company's prospects, but it should be considered alongside other factors when evaluating the company.
Comparison to Industry Standards
- It's difficult to compare this specific transaction to industry standards without knowing the typical insider ownership and trading patterns for comparable companies.
- However, insider buying is generally viewed positively, especially when compared to insider selling.
- Companies like Cabot Corporation (CBT) or Materion Corporation (MTRN) could be considered peers, but a detailed analysis of their insider trading activity would be needed for a meaningful comparison.
Stakeholder Impact
- The increased stake of a director could positively influence shareholder confidence.
- Employees may view this as a positive sign of company stability and growth potential.
Key Dates
| Date | Description |
|---|---|
| 11/17/2016 | Date of grant for several stock appreciation rights (later converted to options) with various exercise prices, expiring on 11/17/2026. |
| 02/21/2018 | Date of grant for options with an exercise price of $0.68, expiring on 02/21/2027, vesting in three equal annual installments. |
| 05/23/2019 | Date of grant for options with an exercise price of $0.82, expiring on 05/23/2028, vesting in three equal annual installments. |
| 06/18/2021 | Date of grant for options with an exercise price of $0.45, expiring on 06/18/2027, vesting in three equal annual installments. |
| 12/28/2022 | Date of grant for options with an exercise price of $4.17, expiring on 12/28/2028, vesting in three equal annual installments. |
| 12/20/2023 | Date of grant for options with an exercise price of $1.165, expiring on 12/20/2029, vesting in three equal annual installments. |
| 12/27/2024 | Date of grant for options with an exercise price of $0.61, expiring on 12/27/2030, vesting in three equal annual installments. |
| 08/21/2024 | Janet Whitmore purchased 4,900 shares at $1.57, 118 shares at $1.59, and 100 shares at $1.57. |
| 08/22/2024 | Janet Whitmore purchased 9,822 shares at $1.60, 100 shares at $1.60, 5,900 shares at $1.59, and 100 shares at $1.60. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.